Facilitated By

San Antonio Medical Foundation

SINGLE ARM STUDY OF ALXN1210 IN COMPLEMENT INHIBITOR TREATMENT-NAIVE ADULT AND ADOLESCENT PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Assanasen, Chatchawin
Funded by
ALEXION PHARMACEUTICALS
Research Start Date
Status
Active
Collaborative Project
Clinical Care
Drug Discovery
Other